Talking to Individuals and Families About Long-Acting Injectables

This resource was created by SMI Adviser content partners and approved by the SMI Adviser clinical expert team for inclusion in the knowledge base.

Long-acting injectable antipsychotics (LAIs) are a pharmacologic strategy for treating individuals who have schizophrenia. Rather than the daily pill-taking required with oral antipsychotics, LAIs are administered by injection at two- to four-week intervals.

This fact sheet provides an overview of potential barriers to using LAIs, possible outcomes and side effects, and how to discuss LAIs with individuals and families.


  • Was this Helpful ?
  • YesNo

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.